MedLife invests €3 million in gene testing

Business Forum

11 July, 2025 at 2:04 PM

Romanian private healthcare network MedLife is investing €3 million in genetic testing and will launch a large-scale genetic testing program, making whole human genome sequencing (WGS) widely available in Romania for the first time.

As part of the program, MedLife is onboarding the most advanced Illumina sequencing equipment, NovaSeq X Plus.

The Illumina NovaSeq X Plus, utilized by leading global centers like the Broad Institute, is capable of processing 2.5 times more human genomes than its predecessor.

Mihai Marcu, CEO & Chairman of the Board MedLife Group, said: "We aim to build a model through which personalized medicine becomes truly possible, and genetic testing—as a key element in this ecosystem—becomes accessible, relevant, and integrated into everyday life for as many Romanians as possible."

This technology will enable rapid and precise analysis of the entire human genome, providing individuals with tailored medical recommendations and lifestyle advice for early disease prevention and health optimization.

MedLife completes Medstar acquisition in Cluj-Napoca

Romanian private healthcare group MedLife has completed the full acquisition of the Medstar group of clinics in Cluj-Napoca.

Industry

MedLife reaches €1 billion market cap at BVB

Romanian private healthcare network MedLife has reached a market capitalisation of €1 billion at the Bucharest Stock Exchange (BVB), around nine years after the company went public.

Real estate

MedLife reports 20% growth in first nine months

MedLife, Romania's largest private healthcare network, announced financial results for the first nine months of 2025. The group recorded consolidated pro-forma revenue of over RON 2.36 billion (€464 million), up 19.5% compared to the same period in 2024. EBITDA pro-forma increased by 20.4% compared to the first nine months of last year.

Industry

MedLife Group records 20% turnover growth in H1 2025

Romanian private healthcare operator MedLife has reported a pro-forma consolidated turnover of RON 1.57 billion (€316 million) in H1 2025, a 20.3% increase compared to the same period in 2024.